Progenics Pharmaceuticals Completes Enrollment in Pivotal Phase 3 CONDOR Study of PyL for the Detection of Prostate Cancer

August 5, 2019

We're not around right now. But you can send us an email and we'll get back to you, asap.

Start typing and press Enter to search